Therapeutic Specific Areas

Latest News

January 6th 2016

Health Canada approved AbbVie’s Humira for the treatment of adults with hidradenitis suppurativa.

FDA Reviews Drug Development

FDA Releases Guidance on Treatment for Duchenne Muscular Dystrophy

Boehringer Gains FDA Approval of COPD Treatment

Dicerna Receives Orphan Drug Designation for PH1 Treatment

October 30th 2014

Pfizer's Trumenba is the first FDA-approved immunization against meningococcal disease for individuals 10-25 years old.

July 1st 2014

European Medicines Agency clarifies advanced-therapy medicinal products classification.